Printer Friendly

New tool aids stem cell engineering for medical research.

ROCHESTER, Minn., August 28, 2014-A Mayo Clinic researcher and his collaborators have developed an online analytic tool that will speed up and enhance the process of re-engineering cells for biomedical investigation.

CellNet is a free-use Internet platform that uses network biology methods to aid stem cell engineering.

Details of CellNet and its application to stem cell engineering are described in two back-to-back papers.

"This free platform has a broad range of uses for all types of cell-based investigations and can potentially offer help to people working on all types of cancer," said Hu Li, investigator in the Mayo Clinic Center for Individualized Medicine. "CellNet will indicate how closely an engineered cell resembles the real counterpart and even suggests ways to adjust the engineering."

The network biology platform contains data on a wide range of cells and details on what is known about those cell types. Researchers say the platform can be applied to almost any study and allows users to refine the engineering process.

In the long term, it should provide a reliable short cut to the early phases of drug development, individualized cancer therapies, and pharmacogenetics.

CellNet uses 21 cell types and tissues and data from 56 published human and mouse engineering studies as a basis for analyzing and predicting cell fate and corresponding engineering strategies.

The platform also offers classification scores to determine differentiation and conversion of induced pluripotent stem cells. It reveals incomplete conversion of engineered microphages and hepatocytes.

CellNet can be used for interrogation of cell fate following expression profiling, by classifying input by cell type, quantifying gene regulatory network status, and identifying aberrant regulators affecting the engineering process. All this is valuable in predicting success of engraftment of cancer tumors in mouse avatars for cancer and drug development research.


Citation: Patrick Cahan et al.; "CellNet: Network Biology Applied to Stem Cell Engineering"; Cell, 2014; 158 (4): 903 DOI: 10.1016/j.cell.2014.07.020

Abstract: http://dx.doi.Org/10.1016/j.cell.2014.07.020 Contact: James Collins,

COPYRIGHT 2014 DataTrends Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Advanced Stem Cell Technology
Publication:Stem Cell Business News
Date:Sep 22, 2014
Previous Article:Central Biobank for drug research.
Next Article:Stem cell global market to reach $10.6 b by 2018.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |